Physiologically Based Pharmacokinetic Model of Brigatinib in Healthy Volunteers and Patients With Cancer. [PDF]
Xu Y +6 more
europepmc +1 more source
Comparative analysis of sex-based, vendor-based, and species differences in cytochrome P450 metabolism. [PDF]
Kinatukara N, Xu X, Shah P.
europepmc +1 more source
Safety, tolerability, pharmacokinetics, and pharmacodynamics of zapnometinib: results from a phase I clinical study. [PDF]
Stenglein S +7 more
europepmc +1 more source
Pharmacokinetics, distribution, metabolism, excretion and safety characterization of ZJCK-6-72: novel DYRK1A inhibitor with optimized brain exposure for Alzheimer's disease therapy. [PDF]
Li Z +15 more
europepmc +1 more source
Development of an isavuconazole physiologically-based pharmacokinetic model for adult and pediatric populations. [PDF]
Choules MP +5 more
europepmc +1 more source
Improving hepatic metabolic function with 3D iPSC-derived human hepatocytes. [PDF]
Pozo Garcia V +7 more
europepmc +1 more source
Prediction of Biomarkers for Hepatocellular Carcinoma Based on Proteomics and Phosphoproteomics. [PDF]
Sun X +7 more
europepmc +1 more source
Assessing ADME gene coverage: An observational study on chloroquine therapy for COVID-19. [PDF]
Zaid N +9 more
europepmc +1 more source
Simulation of Imatinib Pharmacokinetics in pregnant women with chronic myeloid leukemia in the third trimester. [PDF]
Mian P +8 more
europepmc +1 more source
Unraveling enantioselective metabolism: Human cytochrome P450s in arachidonic acid biotransformation. [PDF]
Isse FA, El-Sherbeni AA, El-Kadi AOS.
europepmc +1 more source

